GLI1 and breast carcinoma: Moreover, in 2012 studies by Ramaswamy et al. [1,9] have demonstrated that GLI1 is abnormally expressed in breast cancer tissues and cells, and this was associated with tamoxifen-resistance of the breast cancer cells.